THURSDAY, Feb. 11, 2021 (HealthDay News) — Certain genetic factors in people with Down syndrome may increase their COVID-19 risks. Previous studies have found that people with Down syndrome are 10 times more likely to die from COVID-19, and experts have said they should be among those given priority forContinue Reading

TUESDAY, Feb. 9, 2021 (HealthDay News) — An experimental antiviral drug known as peginterferon lambda can speed up COVID-19 patients’ ability to shed the virus and recover, scientists report. “One of the important things about this treatment that’s different from the other things that have been studied for COVID-19 isContinue Reading

TUESDAY, Feb. 9, 2021 (HealthDay News) — A new drug combination for advanced liver cancer can extend people’s lives substantially more than the long-standing drug of choice, new study findings confirm. The treatment involves two drugs approved to fight various cancers: bevacizumab (Avastin) and atezolizumab (Tecentriq). Avastin, an intravenous (IV)Continue Reading